Latest filing published 22 Apr 2016 for PROGENICS PHARMACEUTICALS INC, €22k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul J. Maddon: trading record in brief
This profile gathers the share dealings of Paul J. Maddon in Progenics Pharmaceuticals Inc. Between 3 January 2006 and 1 December 2010, the trades on record add up to 148 filings.
Market trades split into 12 purchases (€230k) and 57 sales (€9.1M). The net balance comes to €8.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 15 share grants and 64 option exercises. Since January 2016: 1 purchase and no sales on the market.
The median purchase comes to €18k.
The latest filing, published on 22 April 2016, reports an open-market purchase of €22k in Progenics Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul J. Maddon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$4.90Common StockSEC:0001447348-16-000060:0Canonical exit: 1 Mar 2011 (T+90)
- 5,000 shares@ US$4.90Common StockSEC:0001441844-10-000083:0Canonical exit: 1 Mar 2011 (T+90)
- 5,000 shares@ US$4.76Common StockSEC:0001441844-10-000081:0Canonical exit: 30 Jan 2011 (T+90)
- 5,000 shares@ US$4.99Common StockSEC:0001441844-10-000075:0Canonical exit: 2 Jan 2011 (T+90)
- 5,000 shares@ US$4.10Common StockSEC:0001441844-10-000068:0Canonical exit: 30 Nov 2010 (T+90)
- 5,000 shares@ US$4.75Common StockSEC:0001441844-10-000066:0Canonical exit: 31 Oct 2010 (T+90)
- 4,972 shares@ US$4.99Common StockSEC:0001441844-10-000065:0Canonical exit: 14 Oct 2010 (T+90)
- 28 shares@ US$4.98Common StockSEC:0001441844-10-000065:1Canonical exit: 14 Oct 2010 (T+90)
- 5,000 shares@ US$4.99Common StockSEC:0001441844-10-000032:0Canonical exit: 30 Aug 2010 (T+90)
- 505 shares@ US$4.89Common StockSEC:0001441844-10-000030:0Canonical exit: 18 Aug 2010 (T+90)
- 4,495 shares@ US$4.93Common StockSEC:0001441844-10-000030:1Canonical exit: 18 Aug 2010 (T+90)
- 44,723 shares0Common StockSEC:0001441844-10-000028:0
- 18,500 shares@ US$4.88Common StockSEC:0001447348-09-000020:0Canonical exit: 14 Jan 2010 (T+90)
- 66,294 shares0Common StockSEC:0001432664-09-000003:0
- 25,000 shares0Common StockSEC:0001432664-08-000004:0
- 15,000 shares@ US$5.33Common StockSEC:0001266375-07-000078:0
- 15,000 shares@ US$23.49Common StockSEC:0001266375-07-000078:1
- 12,000 shares@ US$5.33Common StockSEC:0001266375-07-000070:0
- 12,000 shares@ US$22.03Common StockSEC:0001266375-07-000070:1
- 1,995 shares@ US$19.03Common StockSEC:0001266375-07-000070:2
- 1,816 shares@ US$22.39Common StockSEC:0001266375-07-000070:3
- 12,000 shares@ US$5.33Common StockSEC:0001266375-07-000069:0
- 12,000 shares@ US$23.39Common StockSEC:0001266375-07-000069:1
- 12,000 shares@ US$5.33Common StockSEC:0001266375-07-000068:0
- 12,000 shares@ US$23.77Common StockSEC:0001266375-07-000068:1
25 of 140 declarations
